PDX1, a key factor in pancreatic embryogenesis, can exhibit antimetastatic activity in pancreatic ductal adenocarcinoma

References

• Dugnani E, Sordi V, Pellegrini S, et al. Gene expression analysis of embryonic pancreas development master regulators and terminal cell fate markers in resected pancreatic cancer: A correlation with clinical outcome. Pancreatology. 2018;18:945–953. doi:10.1016/j.pan.2018.09.00630293872
   PubMed Web of Science ®Google Scholar
• Ansari D, Friess H, Bauden M, Samnegard J, Andersson R. Pancreatic cancer: disease dynamics, tumor biology and the role of the microenvironment. Oncotarget. 2018;9(5):6644–6651. doi:10.18632/oncotarget.2401929464100
   PubMedGoogle Scholar
• Reichert M, Blume K, Kleger A, Hartmann D, von Figura G. Developmental pathways direct pancreatic cancer initiation from its cellular origin. Stem Cells Int. 2016;2016:1–8. doi:10.1155/2016/9298535
   Web of Science ®Google Scholar
• Fischer CG, Wood LD. From somatic mutation to early detection: insights from molecular characterization of pancreatic cancer precursor lesions. J Pathol. 2018;246(4):395–404 doi:10.1002/path.5154
   PubMedGoogle Scholar
• Mostafa ME, Erbarut-Seven I, Pehlivanoglu B, Adsay V. Pathologic classification of “pancreatic cancers”: current concepts and challenges. Chin Clin Oncol. 2017;6(6):59. doi:10.21037/cco.2017.12.0129307199
   PubMedGoogle Scholar
• Ren B, Cui M, Yang G, et al. Tumor microenvironment participates in metastasis of pancreatic cancer. Mol Cancer. 2018;17(1):108. doi:10.1186/s12943-018-0858-130060755
   PubMedGoogle Scholar
• Chitty JL, Filipe EC, Lucas MC, Herrmann D, Cox TR, Timpson P. Recent advances in understanding the complexities of metastasis. F1000Res. 2018;7:1169. doi:10.12688/f1000research.15064.2
   Google Scholar
• Wang S, Huang S, Sun YL. Epithelial-mesenchymal transition in pancreatic cancer: a review. Biomed Res Int. 2017;2017:1–10. doi:10.1155/2017/2646148
   Web of Science ®Google Scholar
• Giovannetti E, van der Borden CL, Frampton AE, Ali A, Firuzi O, Peters GJ. Never let it go: stopping key mechanisms underlying metastasis to fight pancreatic cancer. Semin Cancer Biol. 2017;44:43–59. doi:10.1016/j.semcancer.2017.04.00628438662
   PubMed Web of Science ®Google Scholar
• Le Large TYS, Bijlsma MF, Kazemier G, van Laarhoven HWM, Giovannetti E, Jimenez CR. Key biological processes driving metastatic spread of pancreatic cancer as identified by multi-omics studies. Semin Cancer Biol. 2017;44:153–169. doi:10.1016/j.semcancer.2017.03.00828366542
   PubMed Web of Science ®Google Scholar
• Sverdlov E. Missed druggable cancer hallmark: cancer-stroma symbiotic crosstalk as paradigm and hypothesis for cancer therapy. Bioessays. 2018;40(11):1800079. doi:10.1002/bies.201800079
   Web of Science ®Google Scholar
• Roy N, Takeuchi KK, Ruggeri JM, et al. PDX1 dynamically regulates pancreatic ductal adenocarcinoma initiation and maintenance. Genes Dev. 2016;30(24):2669–2683. doi:10.1101/gad.291021.11628087712
   PubMed Web of Science ®Google Scholar
• Fischer KR, Durrans A, Lee S, et al. Epithelial-to-mesenchymal transition is not required for lung metastasis but contributes to chemoresistance. Nature. 2015;527(7579):472–476. doi:10.1038/nature1574826560033
   PubMed Web of Science ®Google Scholar
• Zheng X, Carstens JL, Kim J, et al. Epithelial-to-mesenchymal transition is dispensable for metastasis but induces chemoresistance in pancreatic cancer. Nature. 2015;527(7579):525–530. doi:10.1038/nature1606426560028
   PubMed Web of Science ®Google Scholar
• Borazanci E, Dang CV, Robey RW, Bates SE, Chabot JA, Von Hoff DD. Pancreatic cancer: “a riddle wrapped in a mystery inside an enigma”. Clin Cancer Res. 2017;23(7):1629–1637. doi:10.1158/1078-0432.CCR-16-207028373361
   PubMed Web of Science ®Google Scholar
• Yu J, Liu SH, Sanchez R, Nemunaitis J, Rozengurt E, Brunicardi FC. PDX1 associated therapy in translational medicine. Ann Transl Med. 2016;4(11):214. doi:10.21037/atm.2016.03.5127386488
   PubMed Web of Science ®Google Scholar
• Kashkin KN, Chernov IP, Didych DA, Sverdlov ED. Construction of a combinatorial library of chimeric tumor-specific promoters. BioTechniques. 2017;63(3). doi:10.2144/000114586
   PubMed Web of Science ®Google Scholar
• Kondratyeva LG, Kashkin KN, Chernov IP, et al. PCNA: a constitutive human promoter for gene expression for functional studies and therapeutic applications. Mol Genet Microbiol Virol. 2018;32(3):137–140. doi:10.3103/S089141681703003X
   Web of Science ®Google Scholar
• Kondratyeva LG, Didych DA, Chernov IP, et al. Dependence of expression of regulatory master genes of embryonic development in pancreatic cancer cells on the intracellular concentration of the master regulator PDX1. Doklady Biochem Biophys. 2017;475(1):259–263. doi:10.1134/S1607672917040056
   PubMed Web of Science ®Google Scholar
• Ganger MT, Dietz GD, Ewing SJ. A common base method for analysis of qPCR data and the application of simple blocking in qPCR experiments. BMC Bioinformatics. 2017;18(1). doi:10.1186/s12859-017-1949-5
   PubMedGoogle Scholar
• Abjalimov IR, Zinovyeva MV, Nikolaev LG, Kopantzeva MR, Kopantzev EP, Sverdlov ED. Expression of transcription factor genes in cell lines corresponding to different stages of pancreatic cancer progression. Doklady Biochem Biophys. 2017;475(1):267–270. doi:10.1134/S160767291704007X
   PubMed Web of Science ®Google Scholar
• Chen Y, LeBleu VS, Carstens JL, et al. Dual reporter genetic mouse models of pancreatic cancer identify an epithelial-to-mesenchymal transition-independent metastasis program. EMBO Mol Med. 2018;10(10):e9085. doi:10.15252/emmm.20180908530120146
   PubMed Web of Science ®Google Scholar
• Krebs AM, Mitschke J, Lasierra Losada M, et al. The EMT-activator Zeb1 is a key factor for cell plasticity and promotes metastasis in pancreatic cancer. Nat Cell Biol. 2017;19(5):518–529. doi:10.1038/ncb351328414315
   PubMed Web of Science ®Google Scholar